Ultralife Corp. (ULBI) Tops Q2 EPS by 3c

Ultralife Corp. (NASDAQ: ULBI) reported Q2 EPS of ($0.08), $0.03 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $17.3 million.

For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.

You May Also Be Interested In

• BofA expects Apple to top analyst expectations on July 30
• KeyBanc's Infra Preview: 'We Highlight CCI and DLR'
• Golden State Water seeks CPUC approval for $5.25M Norwalk system buy